First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.)

Original languageEnglish
Article number101841
JournalJACC: Case Reports
Volume14
DOIs
Publication statusPublished - 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors

    Research areas

  • percutaneous, transcatheter valve therapy, tricuspid regurgitation, valve replacement

ID: 370205442